Crossmark

Chemotherapeutic efficacy of dihydromyricetin ruthenium-p-cymene complex in lung cancer through modulation of the PI3K/β-catenin/AhR signaling cascade

Crossref DOI link: https://doi.org/10.1007/s00210-025-04825-1

Published Online: 2025-12-03

Published Print: 2026-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Manna, Priya

Gayen, Sakuntala

Roy, Souvik
License Information

Text and Data Mining valid from 2025-12-03

Version of Record valid from 2025-12-03
More Information

Article History

Received: 11 October 2025

Accepted: 15 November 2025

First Online: 3 December 2025

Declarations

:

: The Institutional Animal Ethics Committee of NSHM Knowledge Campus, Kolkata (Registration No. 1458/PO/E/S/11/CPCSEA), approved the experimental procedures and issued the IAEC protocol number NCPT/IAEC/007/2023, dated on 20th March 2023.

: The authors declare that they have no conflict of interests.

Document is current

Any future updates will be listed below